<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Priority Setting and Ethics | Verguet Lab at Harvard</title>
    <link>/tag/priority-setting-and-ethics/</link>
      <atom:link href="/tag/priority-setting-and-ethics/index.xml" rel="self" type="application/rss+xml" />
    <description>Priority Setting and Ethics</description>
    <generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><copyright>Â© Verguet Lab</copyright><lastBuildDate>Thu, 23 Jan 2020 00:00:00 +0000</lastBuildDate>
    <image>
      <url>/images/icon_hua2ec155b4296a9c9791d015323e16eb5_11927_512x512_fill_lanczos_center_2.png</url>
      <title>Priority Setting and Ethics</title>
      <link>/tag/priority-setting-and-ethics/</link>
    </image>
    
    <item>
      <title>Health Gains &amp; Financial Risk Protection Afforded by Public Financing of Selected Malaria Interventions in Ethiopia: An ECEA</title>
      <link>/publication/2020_assebe_health_gains/</link>
      <pubDate>Thu, 23 Jan 2020 00:00:00 +0000</pubDate>
      <guid>/publication/2020_assebe_health_gains/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Task-sharing or public finance for the expansion of surgical access in rural Ethiopia: an extended cost-effectiveness analysis</title>
      <link>/publication/2015_shrime_surgery/</link>
      <pubDate>Tue, 29 Dec 2015 00:00:00 +0000</pubDate>
      <guid>/publication/2015_shrime_surgery/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Health Gains and Financial Protection from Pneumococcal Vaccination and Pneumonia Treatment in Ethiopia: Results from an Extended Cost-Effectiveness Analysis</title>
      <link>/publication/2015_johansson_pneumovax/</link>
      <pubDate>Wed, 09 Dec 2015 00:00:00 +0000</pubDate>
      <guid>/publication/2015_johansson_pneumovax/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Comparing the health and social protection effects of measles vaccination strategies in Ethiopia: An extended cost-effectiveness analysis</title>
      <link>/publication/2015_driessen_measles/</link>
      <pubDate>Mon, 15 Jun 2015 00:00:00 +0000</pubDate>
      <guid>/publication/2015_driessen_measles/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Comparing the health and social protection effects of measles vaccination strategies in Ethiopia: An extended cost-effectiveness analysis</title>
      <link>/publication/2015_pecenka_prevention/</link>
      <pubDate>Sun, 03 May 2015 00:00:00 +0000</pubDate>
      <guid>/publication/2015_pecenka_prevention/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Health gains and financial risk protection afforded by public financing of selected interventions in Ethiopia: an extended cost-effectiveness analysis</title>
      <link>/publication/2015_verguet_public_financing/</link>
      <pubDate>Fri, 01 May 2015 00:00:00 +0000</pubDate>
      <guid>/publication/2015_verguet_public_financing/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
